Arvinas, INC Form 4 insider transactions

Arvinas, Inc. Director Leslie V Norwalk was granted 16,025 restricted stock units and options to purchase 23,105 shares of common stock as part of her compensation.

Arvinas, Inc.'s Chief Financial Officer, Andrew Saik, sold 5,700 shares of common stock at $7.61 per share on June 24, 2025, to cover tax withholding obligations related to RSU vesting.

Arvinas Chief Scientific Officer Angela M. Cacace sold 2,583 shares of common stock at $7.49 per share to cover tax withholding obligations related to RSU vesting.

David K. Loomis, Chief Accounting Officer of Arvinas Inc., reports the acquisition of restricted stock units and stock options.

Andrew Saik, CFO of Arvinas, Inc., was granted stock options and restricted stock units on May 9, 2025, according to a recent SEC filing.

Chief Scientific Officer Angela M. Cacace reports the acquisition of restricted stock units and stock options in Arvinas, Inc.

Chief Medical Officer Noah Berkowitz reports the acquisition of restricted stock units and stock options in Arvinas, Inc.

Noah Berkowitz, Chief Medical Officer of Arvinas Inc., sold 8,658 shares of common stock on March 18, 2025, to cover tax withholding obligations related to vesting restricted stock units.

David K. Loomis, Chief Accounting Officer of Arvinas Inc., sold 1,214 shares of common stock on February 24, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Angela M. Cacace, Chief Scientific Officer of Arvinas Inc., sold shares of common stock to cover tax withholding obligations related to vesting of restricted stock units.

Ian Taylor, President of R&D at Arvinas Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Arvinas CEO John Houston sold shares of company stock on February 24, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

David K. Loomis, Chief Accounting Officer of Arvinas Inc., reports the acquisition of restricted stock units and stock options.

Andrew Saik, CFO of Arvinas, Inc., reports the acquisition of restricted stock units and stock options, indicating changes in his beneficial ownership of the company's securities.

Arvinas Inc.'s Chief Scientific Officer, Ian Taylor, reports the acquisition of restricted stock units and stock options, signaling continued alignment with the company's long-term performance.

Chief Medical Officer Noah Berkowitz reports the acquisition of restricted stock units and stock options in Arvinas, Inc.

Angela M. Cacace, Chief Scientific Officer of Arvinas Inc., reports the acquisition of restricted stock units and stock options, signaling potential future ownership in the company.

Arvinas CEO John Houston reports the acquisition of restricted stock units and stock options, signaling continued alignment with the company's long-term performance.

Arvinas Inc.'s Chief Accounting Officer, David K. Loomis, sold shares to cover withholding taxes following the vesting of restricted stock units.

Andrew Saik, CFO of Arvinas, Inc., was granted stock options and restricted stock units (RSUs) on June 24, 2024, as part of an incentive plan.

Angela M. Cacace, Chief Scientific Officer of Arvinas Inc., reports the acquisition of restricted stock units and stock options, signaling changes in her beneficial ownership of the company's securities.

Director Linda Bain reports the acquisition of stock options and restricted stock units (RSUs) in Arvinas, Inc.

Director Everett Cunningham reports the acquisition of restricted stock units and stock options in Arvinas, Inc.

Director Edward Moore Kennedy Jr. reports acquisition of restricted stock units and stock options in Arvinas, Inc.

Director Sunil Agarwal reports acquisition and disposal of Arvinas, Inc. common stock and stock options.

Director Briggs Morrison reports acquisition of restricted stock units and stock options in Arvinas, Inc.

Director John Young reports the acquisition of restricted stock units and stock options in Arvinas, Inc.

Director Leslie Norwalk reports acquisition of stock options and restricted stock units (RSUs) in Arvinas, Inc.

Laurie Smaldone Alsup, a director at Arvinas, Inc., reported the acquisition of restricted stock units and stock options on May 29, 2024.

Randy Teel, Arvinas' Interim Chief Financial Officer, reports acquisition of shares and options related to his new role as Chief Business Officer.